Impact of recent FDA ruling on testosterone replacement therapy (TRT)

Since its discovery in the 1930’s, synthetic and bioidentical testosterone has been used to treat men with symptomatic hypogonadism. The growth of the pharmaceutical industry has evolved a range of options including oral, injectable, nasal bioadhesive and the particularly popular topical formulations